Injectable versatile liquid-solid transformation implants alliance checkpoint blockade for magnetothermal dynamic-immunotherapy

Injectable versatile liquid-solid transformation implants alliance checkpoint blockade for magnetothermal dynamic-immunotherapy

The ongoing circulating energy loss, low reactive oxygen species (ROS) accumulation and poor immunogenicity of tumors make it difficult to induce sufficient immunogenic cell death (ICD) in the tumor immunosuppressive microenvironment (TIME), resulting in unsatisfactory immunotherapy efficacy. Furthe...

Full description

Bibliographic Details
Main Authors:	Mengna Wang, Siyu Deng, Yijia Cao, Hang Zhou, Wei Wei, Kexiao Yu, Youde Cao, Bing Liang
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Materials Today Bio
Subjects:	Magnetothermal Liquid-solid transformation Immunogenic cell death Free radicals CTLA4 checkpoint blockade
Online Access:	http://www.sciencedirect.com/science/article/pii/S259000642200240X

Similar Items

A “biomimetic bone-magnet” with suitable mechanical properties concurrently performs accurate target collection of nanoparticles for magnetothermally driven osteosarcoma thermo-chemotherapy
by: Bing Liang, et al.
Published: (2023-10-01)

Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
by: Junghwa Lee, et al.
Published: (2023-07-01)

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
by: Yasuhiro Maruoka, et al.
Published: (2020-09-01)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
by: Elias A. T. Koch, et al.
Published: (2022-01-01)

Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
by: Ganapathy Sriram, et al.
Published: (2022-12-01)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
by: Elias A. T. Koch, et al.
Published: (2021-07-01)

Dual Responsive Magnetic Drug Delivery Nanomicelles with Tumor Targeting for Enhanced Cancer Chemo/Magnetothermal Synergistic Therapy
by: Zhu J, et al.
Published: (2023-12-01)

Motility Dynamics of T Cells in Tumor-Draining Lymph Nodes: A Rational Indicator of Antitumor Response and Immune Checkpoint Blockade
by: Yasuhiro Kanda, et al.
Published: (2021-09-01)

Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy
by: Ilenia Aversa, et al.
Published: (2020-03-01)

Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor
by: Xinlun Dai, et al.
Published: (2023-12-01)

GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy
by: Zhen Liao, et al.
Published: (2024-04-01)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
by: Zhijia Xia, et al.
Published: (2023-07-01)

Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives
by: Guanglin Cui
Published: (2022-05-01)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01)

Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
by: Nils-Petter Rudqvist, et al.
Published: (2023-12-01)

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade
by: Julie Vackova, et al.
Published: (2021-04-01)

Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer
by: Yuhang Fang, et al.
Published: (2022-10-01)

Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis
by: Zhu H, et al.
Published: (2023-06-01)

Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
by: Qingqing Xiao, et al.
Published: (2023-08-01)

Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
by: Hyungjoo Kim, et al.
Published: (2022-05-01)

Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
by: Yujie Zhao, et al.
Published: (2022-09-01)

Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy
by: Shangqin Sun, et al.
Published: (2021-04-01)

Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
by: Alexander Piening, et al.
Published: (2022-12-01)

Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?
by: Alexander Ciurej, et al.
Published: (2023-12-01)

Enhanced tumor penetration for efficient chemotherapy by a magnetothermally sensitive micelle combined with magnetic targeting and magnetic hyperthermia
by: Yu Wang, et al.
Published: (2022-11-01)

Checkpoint nano-PROTACs for activatable cancer photo-immunotherapy
by: Zhang, Chi, et al.
Published: (2023)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
by: Naisheng Zheng, et al.
Published: (2023-12-01)

Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
by: Yang Hao, et al.
Published: (2022-08-01)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
by: Jing Zhan, et al.
Published: (2023-03-01)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
by: Roberta Zappasodi, et al.
Published: (2022-12-01)

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
by: Baoyuan Zhang, et al.
Published: (2024-02-01)

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
by: Rachel L. Y. Ho, et al.
Published: (2021-07-01)

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
by: Robert A. Szczepaniak Sloane, et al.
Published: (2021-10-01)

Immune checkpoint inhibitors for multiple myeloma immunotherapy
by: Zhaoyun Liu, et al.
Published: (2023-11-01)

Combination approaches with immune checkpoint blockade in cancer therapy
by: Maarten Swart, et al.
Published: (2016-11-01)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
by: Pei-Yi Chu, et al.
Published: (2021-10-01)

Size-Dependent Structural, Magnetic and Magnetothermal Properties of Y<sub>3</sub>Fe<sub>5</sub>O<sub>12</sub> Fine Particles Obtained by SCS
by: Tatiana Kiseleva, et al.
Published: (2022-08-01)

Modern cancer therapy: cryoablation meets immune checkpoint blockade
by: Qi Liu, et al.
Published: (2024-02-01)

Engineering magnetic nano-manipulators for boosting cancer immunotherapy
by: Bin Yan, et al.
Published: (2022-12-01)